Jan 21, 2020
This podcast will discuss the findings from a phase II trial of gemcitabine, cisplatin and PARP inhibitor therapy in germline BRCA/PALB2 mutant pancreatic cancer and discuss an optimal treatment strategy in this setting.
TRANSCRIPT
This JCO Podcast provides observations and commentary on the JCO article “A...
Jan 8, 2020
Towards improved characterization of immune-related adverse events in the setting of pre-existing autoimmune disease.
TRANSCRIPT
This JCO Podcast provides observations and commentary on the JCO article “Immune Checkpoint Inhibitor Therapy in Patients with Preexisting Inflammatory Bowel Disease”, by Abu-Sbeih et al....
Jan 8, 2020
This podcast describes a study examining aerobic capacity in a cohort of over 1200 adult survivors of childhood cancer and related impairments of cardiac, pulmonary and neuromuscular body systems, to understand how aerobic capacity influences all-cause mortality.
TRANSCRIPT
This JCO Podcast provides observations and...
Jan 8, 2020
This podcast describes the results of the BLOOM study, evaluating the efficacy of osimertinib in EGFR-mutated lung cancer with leptomeningeal disease after failure of prior EGFR TKI therapy.
TRANSCRIPT
This JCO Podcast provides observations and commentary on the JCO article “Osimertinib In Patients With...
Jan 8, 2020
This podcast reviews the results of KEYNOTE 164 investigating the use of pembrolizumab for mismatch repair deficient metastatic colorectal cancer, the place of this agent in the current clinical paradigm, and future directions to identify which patients are most likely to benefit from this treatment...